Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

Skin cysts might help advance stem cell treatments to repair skin.

A woman's hair loss led to discovering she had lupus.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Thyroid disorders, especially autoimmune ones, are very common in the studied group.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

The conclusion is that examining the scalp closely and checking for iron levels and thyroid issues is key to understanding chronic hair loss in women.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Hair loss condition FFA was seen before the appearance of skin depigmentation vitiligo in a patient.

Kidney-yang deficiency syndrome causes hormonal imbalances and various physical symptoms.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

People with hypothyroidism and hair loss often have more hair and scalp issues than those without thyroid problems.

Vitamin D may help reduce thyroid antibodies and improve thyroid function in Hashimoto's Thyroiditis.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

circCFAP20DC helps goat ovarian cells grow, aiding follicle development.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

Targeting glycolysis may help treat PCOS by improving insulin sensitivity and ovarian function.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.